160 Health International Limited (02656.HK): Expected Turnaround to Profit in First Half, Net Profit of Approximately RMB 1 Million to 3 Million
NewTimeSpace News: On August 16, 2026, 160 Health International Limited (02656.HK) issued a positive profit alert stating that, based on a preliminary assessment of unaudited consolidated management accounts, it expects to record a net profit of approximately RMB 1 million to 3 million for the reporting period, versus a loss of approximately RMB 19.6 million in the same period last year.
The announcement indicated that the significant improvement in operating performance was primarily attributable to the Group's continuous optimization of its business structure, with the number of partner hospitals operating "160AI Hospital" growing rapidly, driving a steady increase in the number of paid partner healthcare institutions, and boosting the overall revenue growth of the high-margin digital medical health solutions segment. Gross profit increased by approximately RMB 20 million to 24 million year-on-year, representing a year-on-year growth of approximately 31.2% to 37.5%.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- 160 HEALTH (02656.HK): Enters into Strategic Co-operation Framework Agreement with Estimated AI Computing Infrastructure Co-operation Amount of About RMB 650 Million
- 160 HEALTH (02656.HK): Completes delivery of RMB 12.2 million integrated healthcare and AI computing solution, moves into medical AI agent business
- Yangzhou Nanopore Innovative Materials: CSRC Requests Supplementary Materials on Equity Changes Compliance and "Anti-Involution" Policy Alignment